Development of drug discovery screening system by molecular interaction kinetics-mass spectrometry-Reference-Cited by-同舟云学术

Development of drug discovery screening system by molecular interaction kinetics-mass spectrometry

Published:2018-03-25 Issue:8 Volume:32 Page:665-671
ISSN:0951-4198
Container-title:Rapid Communications in Mass Spectrometry
language:en
Short-container-title:Rapid Commun Mass Spectrom

Author:

Obi Naoko¹,Fukuda Tetsuya²,Nakayama Noboru²³,Ervin John⁴,Bando Yasuhiko²,Nishimura Toshihide²³,Nagatoishi Satoru⁵,Tsumoto Kouhei⁶,Kawamura Takeshi⁷⁸^ORCID

Affiliation:

1. Nissha Co. Ltd; Kyoto Japan

2. Biosys Technologies Inc.; Tokyo Japan

3. Translational Medicine Informatics; St Marianna University School of Medicine, Research & Development, Biosys Technologies Inc.; Tokyo Japan

4. Silicon Kinetics Inc.; San Diego CA USA

5. Institute of Medical Science; The University of Tokyo; Tokyo Japan

6. School of Engineering; The University of Tokyo; Tokyo Japan

7. Proteomics Laboratory, Isotope Science Center; The University of Tokyo; Tokyo Japan

8. Laboratories for Systems Biology and Medicine (LSBM), Research Center for Advanced Science and Technology (RCAST); The University of Tokyo; Tokyo Japan

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Analytical Chemistry

Reference27 articles.

1. Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008;Björkholm;J Clin Oncol,2011

2. Strategies for modern biomarker and drug development in oncology;Smith;J Hematol Oncol,2014

3. Key factors in the rising cost of new drug discovery and development;Dickson;Nature Rev Drug Discov,2004

4. FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation;Kim;Clin Cancer Res,2014

5. Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond;Ou;Drug Des Develop Ther,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Competitive Spr Chaser Assay to Study Biomolecular Interactions with Very Slow Binding Dissociation Rate Constant;2024

2. Deep proteome analysis of time-series human plasma samples applied to Covid-19 antibody test;2023-08-24

3. 恩師大橋守先生との50年間の思い出;Journal of the Mass Spectrometry Society of Japan;2022-12-01

4. Advances in MS Based Strategies for Probing Ligand-Target Interactions: Focus on Soft Ionization Mass Spectrometric Techniques;Frontiers in Chemistry;2019-10-23